<?xml version="1.0" encoding="UTF-8"?>
<p id="Par35">This narrative review retrieved and reviewed relevant studies and documents to provide an objective analysis of the COVID-19 treatment utilizing TCMs. The review has the following limitation: the studies included were of varying types (e.g., case observation, clinical trials, blinded versus non-blinded). It was challenging to set general inclusion and exclusion criteria for which studies were included. Although the efficacy of some TCM remedies for COVID-19 is being tested, some trials have not been rigorously designed. Currently, fifteen trials listed in China’s registry expect to enroll more than 2,000 people in studies to rigorously investigate the efficacy and safety of a variety of TCMs in COVID-19, including the most extensive trial assessing 
 <italic>shuanghuanglian</italic> with 400 participants [
 <xref ref-type="bibr" rid="CR72">72</xref>].
</p>
